New User:

Forgot your password?

Stock Market & Financial Investment News

News Breaks
July 2, 2014
07:06 EDTTBIOTransgenomic enters agreement with DNA Technologies
Transgenomic announced that it has entered into an agreement to sell to Integrated DNA Technologies the rights to Transgenomic’s SURVEYOR Nuclease technology and assets for a minimum of $4.25M. Under the terms of the agreement, IDT will make an upfront payment of $3.65M and additional minimum payments of $0.6M or more to Transgenomic during the first year of the agreement. Transgenomic will transfer rights to the SURVEYOR patents, license, technology, know-how and trademarks to IDT, as well as all inventory of the product. As part of the agreement, IDT will exclusively sublicense rights for all clinical and diagnostic applications of the SURVEYOR technology back to Transgenomic. Further terms of the agreement were not disclosed.
News For TBIO From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
April 20, 2015
07:11 EDTTBIOTransgenomic launches ICE-COLD PCR service in biomarket identification business
Transgenomic announced that its groundbreaking Multiplexed ICE COLD PCR technology is now available to pharmaceutical and biotechnology customers of the company’s Biomarker Identification business unit. MX-ICP is an ultra-high sensitivity DNA amplification technology that allows the detection of multiple mutations in multiple genes from any sample, either from a tumor biopsy or from liquids such as blood or urine. MX-ICP is validated and available for use on all sequencing platforms.
April 15, 2015
16:10 EDTTBIOTransgenomic reports Q4 EPS (77c), one estimate (56c)
Reports Q4 revenue $7.7M, one estimate $6.11M.
08:26 EDTTBIOTransgenomic to hold a business news update conference call
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the disclaimer & terms of use